EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Germline PALB2 Genetic Variant Associated with Rapid Metastatic Progression and Poor Survival in Two Kazakh Women with Breast Cancer: A Case Study

Gulnur Zhunussova iD, Nazgul Omarbayeva, Aigul Zhunussova, Diana Abdullayeva, Liliya Skvortsova iD, Nursultan Nurdinov iD, Ainash Oshibayeva iD

Genes · 31.07.2026 · 17 (8) · 913

DOI: 10.3390/genes17080913 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, online erschienen am 31.07.2026. Verfasst von Gulnur Zhunussova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, Germ-Line Mutation, Carcinoma, Ductal, Breast. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germline PALB2 variants are associated with hereditary breast cancer risk, but their clinical impact in Central Asian populations remains largely uncharacterized. This case study aims to evaluate the clinical significance of PALB2 variants in two Kazakh women with early-onset breast cancer.

Methods

Molecular genetic testing identified germline PALB2 pathogenic variants (NM_024675.4:c.18_22delGAAGC and NM_024675.4:c.1034T>G) in two Kazakh women with early-onset invasive ductal carcinoma. Clinical courses, treatment responses, and outcomes were followed.

Results

Neither patient had a reported family history of breast or other malignancies. Patient 1, a 26-year-old pregnant woman, was diagnosed with stage IIIB luminal B, HER2-negative invasive ductal carcinoma and received neoadjuvant chemotherapy, radical surgery, radiotherapy, endocrine therapy, and subsequent treatment for metastatic disease. Despite an initial response, she developed extensive skeletal metastases and died from metastatic breast cancer. Patient 2, a 33-year-old woman, presented with de novo stage IV luminal B, HER2-negative invasive ductal carcinoma with hepatic metastases. Following multimodal treatment, including chemotherapy, surgery, radiotherapy, endocrine suppression, and systemic therapy for disease progression, she experienced further metastatic spread and ultimately died from breast cancer-related complications.

Conclusions

Both patients exhibited aggressive clinical courses characterized by early disease onset, metastatic progression, and poor outcomes despite comprehensive treatment. These cases highlight the potential clinical significance of germline PALB2 variants in apparently sporadic breast cancer and underscore the importance of genetic testing, risk assessment, and genetic counselling in young breast cancer patients, particularly in underrepresented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi Anemia Complementation Group N ProteinBreast NeoplasmsGerm-Line MutationCarcinoma, Ductal, BreastHumansFemaleAdultDisease ProgressionPregnancyKazakhstan

Stichwörter der Autor:innen

KazakhstanPALB2aggressive disease progressionbreast cancergermline varianthereditary breast cancer

Substanzen

Fanconi Anemia Complementation Group N ProteinPALB2 protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
  • Oncology Department, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.
  • Department of Mammology, Kazakh Institute of Oncology and Radiology, Almaty 050022, Kazakhstan.
  • Department of Fundamental Medical Disciplines, Faculty of Dentistry, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan.
  • Department of Public Health and Scientific Research, Faculty of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan.

ORCID-Profile: Gulnur Zhunussova, Liliya Skvortsova, Nursultan Nurdinov, Ainash Oshibayeva

Förderung

  • Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Zhunussova, G., Omarbayeva, N., Zhunussova, A., Abdullayeva, D., Skvortsova, L., Nurdinov, N., & Oshibayeva, A. (2026). Germline PALB2 Genetic Variant Associated with Rapid Metastatic Progression and Poor Survival in Two Kazakh Women with Breast Cancer: A Case Study. Genes, 17(8), 913. https://doi.org/10.3390/genes17080913

Vancouver

Zhunussova G, Omarbayeva N, Zhunussova A, Abdullayeva D, Skvortsova L, Nurdinov N, et al. Germline PALB2 Genetic Variant Associated with Rapid Metastatic Progression and Poor Survival in Two Kazakh Women with Breast Cancer: A Case Study. Genes. 2026;17(8):913. doi:10.3390/genes17080913

BibTeX
@article{Zhunussova2026,
  author = {Zhunussova, Gulnur and Omarbayeva, Nazgul and Zhunussova, Aigul and Abdullayeva, Diana and Skvortsova, Liliya and Nurdinov, Nursultan and Oshibayeva, Ainash},
  title = {Germline PALB2 Genetic Variant Associated with Rapid Metastatic Progression and Poor Survival in Two Kazakh Women with Breast Cancer: A Case Study},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {8},
  pages = {913},
  doi = {10.3390/genes17080913}
}
Kostenlos starten →